Drug Manufacturers - Specialty & Generic | Healthcare
Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems. It provides its products under Orofer, Bevon, Maxtra, Zostum, Metpure, and Eslo brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Market Cap
258132705280
Current Price
1362.3
52 Week Range
889.0 - 1580.0
Previous Close
1335.5
Open
1326.8
Sector
Healthcare
Address
Plot No. P-1 and P-2, IT-BT Park, Phase II M.I.D.C. Hinjawadi, Pune, 411057, India
Phone
+91-20350-70033
Website
https://www.emcure.com
Day Low
1326.8
Day High
1375.0
Dividend Yield
PE Ratio
37.089573
Earnings Per Share
36.73
Beta
EBITDA
14688539648
Book Value
234.596
EPS
49.5
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Satish Ramanlal Mehta | CEO, MD & Executive Director | 73 | 1951 |
Mr. Tajuddin Sabir Shaikh | Chief Financial Officer | - | - |
Mr. Samit Satish Mehta | President of Operations & Whole-Time Director | 42 | 1982 |
Dr. Mukund Keshao Gurjar | Chief Scientific Officer & Whole-Time Director | 72 | 1952 |
Mr. Sunil Rajanikant Mehta | Executive Director of Projects & Whole-Time Director | 61 | 1963 |
Ms. Namita Vikas Thapar | Executive Director of India Business & Whole-Time Director | 47 | 1977 |
Mr. Chetan Rajendra Sharma | Company Secretary & Compliance Officer | 36 | 1988 |
Mr. Naveen Soni | Director of Corporate Communications & Public Relations | - | - |
Mr. Vikas Madan Thapar | President of Corporate Development, Strategy & Finance | 48 | 1976 |
Mr. Rajesh Nair | President of HR | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.